Zobrazeno 1 - 10
of 55
pro vyhledávání: '"MESH : Immunity, Cellular"'
Autor:
Hoa Thi My Vo, Alvino Maestri, Heidi Auerswald, Sopheak Sorn, Sokchea Lay, Heng Seng, Sotheary Sann, Nisa Ya, Polidy Pean, Philippe Dussart, Olivier Schwartz, Sovann Ly, Timothée Bruel, Sowath Ly, Veasna Duong, Erik A. Karlsson, Tineke Cantaert
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Frontiers in Immunology
Frontiers in Immunology, 2022, 13, pp.817905. ⟨10.3389/fimmu.2022.817905⟩
Frontiers in Immunology, Frontiers, 2022, 13, pp.817905. ⟨10.3389/fimmu.2022.817905⟩
Frontiers in Immunology
Frontiers in Immunology, 2022, 13, pp.817905. ⟨10.3389/fimmu.2022.817905⟩
Frontiers in Immunology, Frontiers, 2022, 13, pp.817905. ⟨10.3389/fimmu.2022.817905⟩
The duration of humoral and cellular immune memory following SARS-CoV-2 infection in populations in least developed countries remains understudied but is key to overcome the current SARS-CoV-2 pandemic. Sixty-four Cambodian individuals with laborator
Autor:
Gougeon, Marie-Lise, Poirier-Beaudouin, Béatrice, Ausseil, Jérome, Zérah, Michel, Artaud, Cécile, Heard, Jean-Michel, Deiva, Kumaran, Tardieu, Marc
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Frontiers, 2021, 12, pp.655478. ⟨10.3389/fimmu.2021.655478⟩
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology, 2021, 12, pp.655478. ⟨10.3389/fimmu.2021.655478⟩
Frontiers in Immunology, Frontiers, 2021, 12, pp.655478. ⟨10.3389/fimmu.2021.655478⟩
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology, 2021, 12, pp.655478. ⟨10.3389/fimmu.2021.655478⟩
International audience; Mucopolysaccharidosis type IIIB syndrome (Sanfilippo disease) is a rare autosomic recessif disorder caused by mutations in the α-N-acetylglucosaminidase (NAGLU) gene coding for a lysosomal enzyme, leading to neurodegeneration
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::264181ddb1d95ef2cdef9ef8f1850cc3
https://hal.sorbonne-universite.fr/hal-03241952/file/fimmu-12-655478.pdf
https://hal.sorbonne-universite.fr/hal-03241952/file/fimmu-12-655478.pdf
Autor:
Anne Laure Clairet, Adeline Bouard, Laura Mansi, Christophe Borg, Virginie Westeel, Kevin Bouiller, Emeline Orillard, Gilles Capellier, Louis Bohard, Samuel Limat, Quentin Lepiller, Guillaume Eberst, Catherine Chirouze, Marie Kroemer, Léa Malinowski, Laurie Spehner, Sebastien Pili Floury, Maxime Dubois, Lucie Vettoretti
Publikováno v:
Journal of Infection
Journal of Infection, WB Saunders, 2021, 82 (2), pp.282-327. ⟨10.1016/j.jinf.2020.08.036⟩
Journal of Infection, WB Saunders, 2020, pp.4816. ⟨10.1016/j.jinf.2020.08.036⟩
Journal of Infection, 2021, 82 (2), pp.282-327. ⟨10.1016/j.jinf.2020.08.036⟩
Journal of Infection, WB Saunders, 2021, 82 (2), pp.282-327. ⟨10.1016/j.jinf.2020.08.036⟩
Journal of Infection, WB Saunders, 2020, pp.4816. ⟨10.1016/j.jinf.2020.08.036⟩
Journal of Infection, 2021, 82 (2), pp.282-327. ⟨10.1016/j.jinf.2020.08.036⟩
International audience; Adaptive Immune responses generated by SARS-CoV-2 virus in convalescent patients according to disease severity remain poorly characterized. To this end, we designed a prospective study (NCT04365322) that included 60 COVID-19 c
Autor:
Frédéric Tangy, Thierry Huet, Pierre Langlade-Demoyen, Christelle Liard, Marion Julithe, Marie Escande, Chantal Combredet, Jessie Thalmensi, Simon Wain-Hobson, Elodie Pliquet, Claude Ruffié, Thomas Bestetti, Valérie Najburg
Publikováno v:
Cancer Immunology, Immunotherapy
Cancer Immunology, Immunotherapy, 2019, 68 (4), pp.533-544. ⟨10.1007/s00262-018-2272-3⟩
Cancer Immunology, Immunotherapy, Springer Verlag, 2019, 68 (4), pp.533-544. ⟨10.1007/s00262-018-2272-3⟩
Cancer Immunology, Immunotherapy, 2019, 68 (4), pp.533-544. ⟨10.1007/s00262-018-2272-3⟩
Cancer Immunology, Immunotherapy, Springer Verlag, 2019, 68 (4), pp.533-544. ⟨10.1007/s00262-018-2272-3⟩
International audience; Cancer immunotherapy is seeing an increasing focus on vaccination with tumor-associated antigens (TAAs). Human telomerase (hTERT) is a TAA expressed by most tumors to overcome telomere shortening. Tolerance to hTERT can be eas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f044afa53550131a805a172fa5811146
https://hal-pasteur.archives-ouvertes.fr/pasteur-03232227
https://hal-pasteur.archives-ouvertes.fr/pasteur-03232227
Autor:
Anne-Pauline Bellanger, Laurence Millon, Bénédicte Rognon, Houssein Gbaguidi-Haore, Thibaud Lignon, Christophe Borg, Gabriel Reboux, Yann Godet
Publikováno v:
Journal of Immunological Methods
Journal of Immunological Methods, Elsevier, 2017, 440, pp.67-73. ⟨10.1016/j.jim.2016.11.009⟩
Journal of Immunological Methods, Elsevier, 2016, 440, pp.67-73
Journal of Immunological Methods, Elsevier, 2017, 440, pp.67-73. 〈10.1016/j.jim.2016.11.009〉
Journal of Immunological Methods, Elsevier, 2017, 440, pp.67-73. ⟨10.1016/j.jim.2016.11.009⟩
Journal of Immunological Methods, Elsevier, 2016, 440, pp.67-73
Journal of Immunological Methods, Elsevier, 2017, 440, pp.67-73. 〈10.1016/j.jim.2016.11.009〉
International audience; Hypersensitivity pneumonitis (HP) is an immunoallergic disease due to chronic exposure to high quantities of different microorganisms such as Mycobacterium immunogenum (Mi), a mycobacterium, and Lichtheimia corymbifera (Lc), a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e450e701d020baf82eb20a466966f90b
https://hal.archives-ouvertes.fr/hal-01667667
https://hal.archives-ouvertes.fr/hal-01667667
Autor:
Florence Boisgerault, Federico Mingozzi, Romain Hardet, Helena Costa Verdera, Giuseppe Ronzitti, Alicia M. Michaud, Fanny Collaud, Amine Meliani, Giorgia Manni, Severine Charles, Alban Vignaud, Christian Leborgne, Petr Ilyinskii, Takashi Kei Kishimoto, Marcelo Simon Sola, Francesca Fallarino, Olivier D. Christophe, Solenne Marmier, Christopher J. Roy, Laetitia van Wittenberghe
Publikováno v:
Nature Communications
Nature Communications, Nature Publishing Group, 2018, 9 (1), pp.4098. ⟨10.1038/s41467-018-06621-3⟩
Nature Communications, Vol 9, Iss 1, Pp 1-13 (2018)
Nature Communications, 2018, 9 (1), pp.4098. ⟨10.1038/s41467-018-06621-3⟩
Nature Communications, Nature Publishing Group, 2018, 9 (1), pp.4098. ⟨10.1038/s41467-018-06621-3⟩
Nature Communications, Vol 9, Iss 1, Pp 1-13 (2018)
Nature Communications, 2018, 9 (1), pp.4098. ⟨10.1038/s41467-018-06621-3⟩
Gene therapy mediated by recombinant adeno-associated virus (AAV) vectors is a promising treatment for systemic monogenic diseases. However, vector immunogenicity represents a major limitation to gene transfer with AAV vectors, particularly for vecto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e609f78e07de4ba083e8423956027be
http://hdl.handle.net/11391/1439292
http://hdl.handle.net/11391/1439292
Autor:
Ying Qi, James J. Goedert, David W. Haas, Maureen P. Martin, Huabiao Chen, M. H. Tsai, Jacques Fellay, Otto O. Yang, Steven M. Wolinsky, Philippa C Matthews, Philip J. R. Goulder, Christian B. Willberg, Jeremy J. Martinson, Mary Carrington, Søren Buus, Asier Sáez-Cirión, Fabian Chen, Jeffrey N. Martin, Steven G. Deeks, Ellen M. Leitman, Bruce D. Walker, Alicja Piechocka-Trocha, Lynn Riddell
Publikováno v:
Journal of virology
Journal of Virology
Journal of Virology, American Society for Microbiology, 2017, 91 (22), pp.e00544-17. ⟨10.1128/JVI.00544-17⟩
Journal of Virology, 2017, 91 (22), pp.e00544-17. ⟨10.1128/JVI.00544-17⟩
Journal of virology, vol 91, iss 22
Leitman, EM; Willberg, CB; Tsai, M-H; Chen, H; Buus, S; Chen, F; et al.(2017). HLA-B*14:02-Restricted Env-Specific CD8(+) T-Cell Activity Has Highly Potent Antiviral Efficacy Associated with Immune Control of HIV Infection. JOURNAL OF VIROLOGY, 91(22). doi: 10.1128/JVI.00544-17. UCLA: Retrieved from: http://www.escholarship.org/uc/item/3bf423g3
Leitman, E M, Willberg, C B, Tsai, M H, Chen, H, Buus, S, Chen, F, Riddell, L, Haas, D, Fellay, J, Goedert, J J, Piechocka-Trocha, A, Walker, B D, Martin, J, Deeks, S, Wolinsky, S M, Martinson, J, Martin, M, Qi, Y, Sáez-Cirión, A, Yang, O O, Matthews, P C, Carrington, M & Goulder, P J R 2017, ' HLA-B*14 : 02-restricted Env-specific CD8 + T-cell activity has highly potent antiviral efficacy associated with immune control of HIV infection ', Journal of Virology, vol. 91, no. 22, e00544-17 . https://doi.org/10.1128/JVI.00544-17
Journal of Virology
Journal of Virology, American Society for Microbiology, 2017, 91 (22), pp.e00544-17. ⟨10.1128/JVI.00544-17⟩
Journal of Virology, 2017, 91 (22), pp.e00544-17. ⟨10.1128/JVI.00544-17⟩
Journal of virology, vol 91, iss 22
Leitman, EM; Willberg, CB; Tsai, M-H; Chen, H; Buus, S; Chen, F; et al.(2017). HLA-B*14:02-Restricted Env-Specific CD8(+) T-Cell Activity Has Highly Potent Antiviral Efficacy Associated with Immune Control of HIV Infection. JOURNAL OF VIROLOGY, 91(22). doi: 10.1128/JVI.00544-17. UCLA: Retrieved from: http://www.escholarship.org/uc/item/3bf423g3
Leitman, E M, Willberg, C B, Tsai, M H, Chen, H, Buus, S, Chen, F, Riddell, L, Haas, D, Fellay, J, Goedert, J J, Piechocka-Trocha, A, Walker, B D, Martin, J, Deeks, S, Wolinsky, S M, Martinson, J, Martin, M, Qi, Y, Sáez-Cirión, A, Yang, O O, Matthews, P C, Carrington, M & Goulder, P J R 2017, ' HLA-B*14 : 02-restricted Env-specific CD8 + T-cell activity has highly potent antiviral efficacy associated with immune control of HIV infection ', Journal of Virology, vol. 91, no. 22, e00544-17 . https://doi.org/10.1128/JVI.00544-17
Immune control of human immunodeficiency virus type 1 (HIV) infection is typically associated with effective Gag-specific CD8 + T-cell responses. We here focus on HLA-B*14, which protects against HIV disease progression, but the immunodominant HLA-B*
Study on 43 patients with lymphoma and a « Common Variable Immunodeficiency (CVID) – like » disorder
Autor:
Allain, Vincent
Publikováno v:
Médecine humaine et pathologie. 2017
In patients with a diagnosis of Common Variable Immunodeficiency (CVID), about 5% will develop a lymphomaduring the course of the disease. Little is known about the characteristics of these patients and lymphomas. Todate, lymphoma remains an exclusio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2592::715bff89de05ed6e7717af4f3637aaff
https://dumas.ccsd.cnrs.fr/dumas-02474488/document
https://dumas.ccsd.cnrs.fr/dumas-02474488/document
Autor:
Belkacem, Nouria, Serafini, Nicolas, Wheeler, Richard, Derrien, Muriel, Boucinha, Lilia, Couesnon, Aurélie, Cerf-Bensussan, Nadine, Gomperts Boneca, Ivo, Di Santo, James, Taha, Muhamed-Kheir, Bourdet-Sicard, Raphaelle, Sun, Jie
Publikováno v:
PLoS ONE
PLoS ONE, Public Library of Science, 2017, 12 (9), pp.e0184976. ⟨10.1371/journal.pone.0184976⟩
PLoS ONE, 2017, 12 (9), pp.e0184976. ⟨10.1371/journal.pone.0184976⟩
PLoS ONE, Vol 12, Iss 9, p e0184976 (2017)
PLoS ONE, Public Library of Science, 2017, 12 (9), pp.e0184976. ⟨10.1371/journal.pone.0184976⟩
PLoS ONE, 2017, 12 (9), pp.e0184976. ⟨10.1371/journal.pone.0184976⟩
PLoS ONE, Vol 12, Iss 9, p e0184976 (2017)
International audience; Respiratory tract infections such as flu cause severe morbidity and mortality and are among the leading causes of death in children and adults worldwide. Commensal microbiota is critical for orchestrating tissue homeostasis an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::f6c976b3b2cdb95c4991dcb6962643a2
https://hal-pasteur.archives-ouvertes.fr/pasteur-02013238/document
https://hal-pasteur.archives-ouvertes.fr/pasteur-02013238/document
Autor:
Soumaya Marzouki, Melika Ben Ahmed, Jihene Bettaieb, Ines Bini Dhouib, Saloua El Fazaa, Chaouki Benabdessalem, Ammar Maroueni, Mohamed-Ridha Barbouche, Zakaria Bellasfar, Raoudha Doghri, Raja Rekik
Publikováno v:
Life Sciences
Life Sciences, Elsevier, 2018, 188, pp.10-16. ⟨10.1016/j.lfs.2017.08.022⟩
Life Sciences, Elsevier, 2018, 188, pp.10-16. ⟨10.1016/j.lfs.2017.08.022⟩
Aims Acetamiprid (ACE) is an insecticide of the neonicotinoid family, the most widely used in the world. Herein, we assessed the effect of ACE on either the humoral or cellular immune responses of rodents. We also evaluated the role of curcumin in th